Sodium Selenite

亚硒酸钠

Report date: 2024/11/25 10:09:23
NME

Base Information

Drug NameSodium Selenite
Drug Alias NameSelenasesk-03014
ClassificationSmall molecules > Inorganic and minerals salt
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasmsselenium deficiencyHeart Diseases +[7] 
Global Approved Indicationsselenium deficiencyKashin-Beck Disease
Approved Indications in Chinaselenium deficiencyKashin-Beck Disease
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Hi Tech Group Tianjian Pharmaceutical Development Co LtdFujimoto PharmaceuticalBiosyn Arzneimittel Gmbh
Inactive CompaniesStanford UniversityNational Cancer Institute
Active Indicationsselenium deficiencyKashin-Beck Disease
Inactive IndicationsHormone-Resistant Prostate NeoplasmsHeart DiseasesProstatic Neoplasms +[5] 

Other Information

ATC CodeA12CE02
Related LinksWikipediaKEGG